Market Tracker

08/31 10:23am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.22
BATS BZX Real-Time Price
As of 10:21am ET
 -0.03 / -0.71%
Today’s Change
2.80
Today|||52-Week Range
7.80
-16.44%
Year-to-Date

Today’s Trading

Previous close4.25
Today’s open4.23
Day’s range4.16 - 4.26
Volume12,269
Average volume (3 months)1,617,749
Market cap$457.5M
Dividend yield--
Data as of 10:21am ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)-2.96%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book5.22

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Internatio...-0.21-2.34%
ACRSAclaris Therapeutics...-0.19-0.90%
PGNXProgenics Pharmaceut...-0.14-2.17%
FLXNFlexion Therapeutics...-0.07-0.41%
Data as of 10:22am ET, 08/31/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts